³í¹®) SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease ¼¼ºê¶õ½ºº´¿ø ±èÁß¼±(½ÉÀå³»°ú)·ÀÌ¿ëÈ£(³»ºÐºñ³»°ú)·ÀÌ»ó±¹(Áø´Ü°Ë»çÀÇÇаú) ±³¼ö¿Í ¿ëÀμ¼ºê¶õ½ºº´¿ø ÀÔ¿øÀÇÇаú ±è¼Ò¶ó ±³¼ö °øµ¿¿¬±¸ÆÀ